Journal: bioRxiv
Article Title: A comprehensive genetic catalog of human double-strand break repair
doi: 10.1101/2024.08.03.606369
Figure Lengend Snippet: (A) Summary of results obtained in the screen for HLTF, as in . Only data for TKOv3 Cut site 2 is displayed. (B) Impact of knocking HLTF out on the repair profile produced at TKOv3 Cut site 2 in RPE1- Cas9 TKOv3 cells. Assay performed as in . Three independent HLTF -/- clones are shown. n = 3, except for clone 9 (n = 4), error bars show ±SD. (C) Effect of PCNA on the repair profile of wild type and HLTF -/- RPE1- Cas9 TKOv3 cells. After transfection with NT or PCNA -targeting gRNAs, cells are arrested in G0/G1 by confluency for 12 days and then transfected with the TKOv3 Cut site 2 gRNA. Genomic DNA is purified three days later. n = 3 for WT + NT gRNA, n = 5 for WT + PCNA gRNA, n = 2 for HLTF -/- + NT gRNA and n = 5 for HLTF -/- + PCNA gRNA. Error bars show ±SD. (D) Repair pattern obtained at AAVS1 cut site 4 in the RPE1- Cas9 HLTF -/- cell line complemented with the indicated versions of HLTF . Doxycycline is added to induce HLTF expression (figure S5C) 24 hours before transfection with AAVS1 cut site 4 gRNA, and it is maintained until genomic DNA purification (3 days after transfection). Only most frequent indels are shown. n = 3 except for the RING mutant (n = 2). Error bars show ±SD. (E) ChIP q-PCR experiments showing HLTF binding to TKOv3 Cut site 2 in the indicated genotypes at 0 and 3 hours after transfection with TKOv3 Cut site 2 gRNA. GREB1 locus was used as a control site. n = 3, error bars show ±SD. Statistical analysis was performed using Two-way ANOVA. (F) (left) ChIP q-PCR experiments showing Cas9 binding to TKOv3 Cut site 2 in the indicated genotypes at different time points after transfection with the TKOv3 Cut site 2 gRNA. GREB1 locus was used as a control site. (right) Cas9 cleavage efficiency at TKOv3 Cut site 2 estimated by qPCR (as in ) in the same samples used for Cas9 ChIP experiments in wild type and HLTF -/- backgrounds. n = 3, error bars show ±SD. Statistical analysis was performed using Two-way ANOVA. (G) Experimental layout diagram for the in vitro removal of post-cleavage Cas9 RNP by HLTF (left, see figure S5F and Methods). Immobilized dsDNA, containing the TKOv3 Cut 2 gRNA target sequence, is digested by the addition of TKOv3 Cut 2 gRNA-Cas9 RNP. Retained Cas9 RNP is then released by incorporation of increasing bacteria-purified HLTF concentrations to the mix. (Right) Representative electrophoresis gel image of flow-through material after incubation with HLTF. Normalized quantification of the released Cas9 bands is shown below the electrophoresis image.
Article Snippet: RPE1 Cas9 TKOv3-NT and RPE1 Cas9 TP53 -/- TKOv3-NT cell lines were generated by lentiviral transduction using the TKOv3 library backbone plasmid (pLCKO2, Addgene #125518) with a non-targeting gRNA sequence cloned into the BsmB1 restriction sites.
Techniques: Produced, Clone Assay, Transfection, Purification, Expressing, DNA Purification, Mutagenesis, Binding Assay, Control, In Vitro, Sequencing, Bacteria, Electrophoresis, Incubation